160 related articles for article (PubMed ID: 23344729)
1. The permissive effects of glucose on receptor-operated potentiation of insulin secretion from mouse islets: a role for ERK1/2 activation and cytoskeletal remodelling.
Bowe JE; Chander A; Liu B; Persaud SJ; Jones PM
Diabetologia; 2013 Apr; 56(4):783-91. PubMed ID: 23344729
[TBL] [Abstract][Full Text] [Related]
2. Kisspeptin stimulation of insulin secretion: mechanisms of action in mouse islets and rats.
Bowe JE; King AJ; Kinsey-Jones JS; Foot VL; Li XF; O'Byrne KT; Persaud SJ; Jones PM
Diabetologia; 2009 May; 52(5):855-62. PubMed ID: 19221709
[TBL] [Abstract][Full Text] [Related]
3. G protein-coupled receptor (GPR)40-dependent potentiation of insulin secretion in mouse islets is mediated by protein kinase D1.
Ferdaoussi M; Bergeron V; Zarrouki B; Kolic J; Cantley J; Fielitz J; Olson EN; Prentki M; Biden T; MacDonald PE; Poitout V
Diabetologia; 2012 Oct; 55(10):2682-2692. PubMed ID: 22820510
[TBL] [Abstract][Full Text] [Related]
4. GPR54 peptide agonists stimulate insulin secretion from murine, porcine and human islets.
Bowe JE; Foot VL; Amiel SA; Huang GC; Lamb MW; Lakey J; Jones PM; Persaud SJ
Islets; 2012; 4(1):20-3. PubMed ID: 22192948
[TBL] [Abstract][Full Text] [Related]
5. Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
Winzell MS; Ahrén B
J Mol Endocrinol; 2008 Feb; 40(2):93-100. PubMed ID: 18234911
[TBL] [Abstract][Full Text] [Related]
6. Evaluating insulin secretagogues in a humanized mouse model with functional human islets.
Luo J; Nguyen K; Chen M; Tran T; Hao J; Tian B; Rulifson IC; Zhang Y; Tian L; Zhang Y; Lopez E; Lin DC; Wang Y; Ma Z; Houze J; Guo Z
Metabolism; 2013 Jan; 62(1):90-9. PubMed ID: 22982177
[TBL] [Abstract][Full Text] [Related]
7. Activation of the extracellular calcium-sensing receptor initiates insulin secretion from human islets of Langerhans: involvement of protein kinases.
Gray E; Muller D; Squires PE; Asare-Anane H; Huang GC; Amiel S; Persaud SJ; Jones PM
J Endocrinol; 2006 Sep; 190(3):703-10. PubMed ID: 17003271
[TBL] [Abstract][Full Text] [Related]
8. Protein farnesylation-dependent Raf/extracellular signal-related kinase signaling links to cytoskeletal remodeling to facilitate glucose-induced insulin secretion in pancreatic beta-cells.
Kowluru A; Veluthakal R; Rhodes CJ; Kamath V; Syed I; Koch BJ
Diabetes; 2010 Apr; 59(4):967-77. PubMed ID: 20071600
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
10. Regulation of pancreatic beta-cell insulin secretion by actin cytoskeleton remodelling: role of gelsolin and cooperation with the MAPK signalling pathway.
Tomas A; Yermen B; Min L; Pessin JE; Halban PA
J Cell Sci; 2006 May; 119(Pt 10):2156-67. PubMed ID: 16638805
[TBL] [Abstract][Full Text] [Related]
11. Activation of extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) by free fatty acid receptor 1 (FFAR1/GPR40) protects from palmitate-induced beta cell death, but plays no role in insulin secretion.
Panse M; Gerst F; Kaiser G; Teutsch CA; Dölker R; Wagner R; Häring HU; Ullrich S
Cell Physiol Biochem; 2015; 35(4):1537-45. PubMed ID: 25792236
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y promotes beta-cell replication via extracellular signal-regulated kinase activation.
Cho YR; Kim CW
Biochem Biophys Res Commun; 2004 Feb; 314(3):773-80. PubMed ID: 14741702
[TBL] [Abstract][Full Text] [Related]
13. The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways.
Favaro E; Granata R; Miceli I; Baragli A; Settanni F; Cavallo Perin P; Ghigo E; Camussi G; Zanone MM
Diabetologia; 2012 Apr; 55(4):1058-70. PubMed ID: 22231124
[TBL] [Abstract][Full Text] [Related]
14. ERK1 is dispensable for mouse pancreatic beta cell function but is necessary for glucose-induced full activation of MSK1 and CREB.
Leduc M; Richard J; Costes S; Muller D; Varrault A; Compan V; Mathieu J; Tanti JF; Pagès G; Pouyssegur J; Bertrand G; Dalle S; Ravier MA
Diabetologia; 2017 Oct; 60(10):1999-2010. PubMed ID: 28721437
[TBL] [Abstract][Full Text] [Related]
15. Glucose-stimulated insulin secretion from rat islets of Langerhans is independent of mitogen-activated protein kinase activation.
Burns CJ; Howell SL; Jones PM; Persaud SJ
Biochem Biophys Res Commun; 1997 Oct; 239(2):447-50. PubMed ID: 9344849
[TBL] [Abstract][Full Text] [Related]
16. Improved human islet preparations using glucocorticoid and exendin-4.
Miki A; Ricordi C; Yamamoto T; Sakuma Y; Misawa R; Mita A; Inverardi L; Alejandro R; Ichii H
Pancreas; 2014 Nov; 43(8):1317-22. PubMed ID: 25036907
[TBL] [Abstract][Full Text] [Related]
17. Role of protein kinase C, PI3-kinase and tyrosine kinase in activation of MAP kinase by glucose and agonists of G-protein coupled receptors in INS-1 cells.
Böcker D; Verspohl EJ
Int J Exp Diabetes Res; 2001; 2(3):233-44. PubMed ID: 12369712
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of cannabinoid receptors in mouse islets.
Li C; Bowe JE; Jones PM; Persaud SJ
Islets; 2010; 2(5):293-302. PubMed ID: 21099327
[TBL] [Abstract][Full Text] [Related]
19. Insulin receptor activation inhibits insulin secretion from human islets of Langerhans.
Persaud SJ; Asare-Anane H; Jones PM
FEBS Lett; 2002 Jan; 510(3):225-8. PubMed ID: 11801259
[TBL] [Abstract][Full Text] [Related]
20. Kisspeptin-13 inhibits insulin secretion without affecting glucagon or somatostatin release: study in the perfused rat pancreas.
Silvestre RA; Egido EM; Hernández R; Marco J
J Endocrinol; 2008 Feb; 196(2):283-90. PubMed ID: 18252951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
